Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.014 EUR | -3.45% | -6.67% | 0.00% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 13.38M 9.85M 9.13M |
---|---|---|---|---|---|
Net income 2021 | -1M -736K -682K | Net income 2022 | -1M -736K -682K | EV / Sales 2021 | - |
Net Debt 2021 | 2.91M 2.14M 1.99M | Net Debt 2022 | 3.29M 2.42M 2.24M | EV / Sales 2022 | - |
P/E ratio 2021 |
-7.36
x | P/E ratio 2022 |
-8.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.91% |
1 day | -3.45% | ||
1 week | -6.67% | ||
6 months | -6.67% |
Managers | Title | Age | Since |
---|---|---|---|
Alicia Rebman
FOU | Founder | - | 14-12-14 |
Chief Executive Officer | - | 14-12-14 | |
Harry Parekh
FOU | Founder | - | 14-12-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 23-02-16 | |
Founder | 73 | 14-12-14 | |
Chief Executive Officer | - | 14-12-14 |
Date | Price | Change |
---|---|---|
24-03-28 | 0.014 | -3.45% |
24-03-27 | 0.0145 | +3.57% |
24-03-26 | 0.014 | -6.67% |
24-03-25 | 0.015 | 0.00% |
24-03-22 | 0.015 | 0.00% |
Delayed Quote Deutsche Boerse AG, March 28, 2024 at 03:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.77% | 210B | |
+1.04% | 210B | |
-6.73% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock PreveCeutical Medical Inc.
- Stock PreveCeutical Medical Inc. - Deutsche Boerse AG